Selective publication in reporting results of antidepressant trials exaggerates the effectiveness of the drugs, according to a new report. Researchers examined reviews from the Food and Drug Administration (FDA) for trials of 12 widely prescribed antidepressant drugs approved between 1981 and 2004, involving 12,564 patients. Whether and how the studies were published depended on how they turned out, they found.



Recent comments
29 weeks 4 days ago